Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis
- PMID: 2185329
- PMCID: PMC2187884
- DOI: 10.1084/jem.171.5.1567
Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis
Abstract
Non-MHC-restricted killer cells are cytotoxic lymphocytes that can mediate cytolysis of most tumor targets without apparent selectivity and restriction by the MHC, particularly when activated with IL-2. These effector cells include predominantly NK cells and T cells expressing the TCR-gamma/delta. We found that TCR-gamma/delta-1+, delta TSC1-, BB3+, Ti gamma A+ T cell clones mediate a characteristic cytolytic pattern of non-MHC-restricted cytolysis that is markedly different from NK clones and alpha/beta T cell clones derived from the peripheral blood of the same normal individuals. The characteristic finding is that all BB3/Ti gamma A+ gamma/delta clones mediate strong cytolysis of Daudi cells but they do not lyse Raji cells. In contrast, NK clones from the same donors mediate strong cytolysis of both Daudi and Raji targets. Cytotoxicity by the gamma/delta clones on certain target cells such as Daudi and Molt 4 can be specifically inhibited by mAbs reactive against the TCR-gamma/delta. Therefore, the TCR-gamma/delta on these clones either directly recognizes target epitopes on some tumor targets or it is involved in the regulation of their cytotoxic function. The expression of TCR-gamma/delta products reacting with the BB3 and Ti gamma A mAbs reflects the usage of identical TCR-gamma/delta V region genes that appear to be associated with the characteristic pattern of non-MHC-restricted cytotoxicity displayed by this major subset of human peripheral blood gamma/delta cells.
Similar articles
-
Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.J Immunol. 1989 Jun 15;142(12):4161-8. J Immunol. 1989. PMID: 2470816
-
MHC-unrestricted cytotoxic and proliferative responses of two distinct human gamma/delta T cell subsets to Daudi cells.J Immunol. 1992 Apr 15;148(8):2315-23. J Immunol. 1992. PMID: 1532810
-
[NK-like cytotoxicity of allospecific gamma delta TCR+ T cell clones].Hum Cell. 1990 Oct;3(3):220-5. Hum Cell. 1990. PMID: 1706201 Japanese.
-
Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans.Immunol Rev. 1989 Oct;111:145-75. doi: 10.1111/j.1600-065x.1989.tb00545.x. Immunol Rev. 1989. PMID: 2697680 Review.
-
Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules.Int J Cancer Suppl. 1992;7:15-8. Int J Cancer Suppl. 1992. PMID: 1428398 Review.
Cited by
-
Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans.Infect Immun. 1991 Oct;59(10):3393-7. doi: 10.1128/iai.59.10.3393-3397.1991. Infect Immun. 1991. PMID: 1894353 Free PMC article.
-
Different composition of the human and the mouse gammadelta T cell receptor explains different phenotypes of CD3gamma and CD3delta immunodeficiencies.J Exp Med. 2007 Oct 29;204(11):2537-44. doi: 10.1084/jem.20070782. Epub 2007 Oct 8. J Exp Med. 2007. PMID: 17923503 Free PMC article.
-
Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.Cancer Immunol Immunother. 1994 Nov;39(5):305-12. doi: 10.1007/BF01519983. Cancer Immunol Immunother. 1994. PMID: 7987862 Free PMC article.
-
Application of the direct beta counter Matrix 96 for cytotoxic assays: simultaneous processing and reading of 96 wells using a 51Cr-retention assay.Cancer Immunol Immunother. 1993 Jun;36(6):351-6. doi: 10.1007/BF01742250. Cancer Immunol Immunother. 1993. PMID: 8500108 Free PMC article.
-
CTLs heterogeneity and plasticity: implications for cancer immunotherapy.Mol Cancer. 2024 Mar 21;23(1):58. doi: 10.1186/s12943-024-01972-6. Mol Cancer. 2024. PMID: 38515134 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials